Ashraf Omar

796 total citations
21 papers, 230 citations indexed

About

Ashraf Omar is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Ashraf Omar has authored 21 papers receiving a total of 230 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 12 papers in Hepatology and 4 papers in Surgery. Recurrent topics in Ashraf Omar's work include Liver Disease Diagnosis and Treatment (11 papers), Hepatitis C virus research (8 papers) and Hepatitis B Virus Studies (5 papers). Ashraf Omar is often cited by papers focused on Liver Disease Diagnosis and Treatment (11 papers), Hepatitis C virus research (8 papers) and Hepatitis B Virus Studies (5 papers). Ashraf Omar collaborates with scholars based in Egypt, United States and Jordan. Ashraf Omar's co-authors include Ahmed Khairy, Ghassan K. Abou‐Alfa, Heba Omar, Abeer A. Bahnassy, Hanaa M. Alam El-Din, Abdel‐Rahman N. Zekri, Mahmoud M. Ramadan, Hussein Khaled, Magdy El‐Serafy and Gamal Esmat and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Immunology and Nature Reviews Gastroenterology & Hepatology.

In The Last Decade

Ashraf Omar

19 papers receiving 223 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ashraf Omar Egypt 9 124 119 34 32 20 21 230
Danyi Zeng China 10 71 0.6× 87 0.7× 49 1.4× 20 0.6× 15 0.8× 16 299
Isabelle Fouchard France 8 127 1.0× 161 1.4× 24 0.7× 28 0.9× 4 0.2× 20 281
Siddhartha Ghosh India 9 71 0.6× 129 1.1× 125 3.7× 39 1.2× 25 1.3× 27 365
Pei‐Mei Shi China 8 112 0.9× 129 1.1× 26 0.8× 70 2.2× 8 0.4× 14 229
Jiyun Park South Korea 11 57 0.5× 149 1.3× 39 1.1× 37 1.2× 5 0.3× 35 309
Wanqing Liu United States 5 56 0.5× 219 1.8× 43 1.3× 32 1.0× 13 0.7× 6 300
Flaminia Ferri Italy 10 138 1.1× 157 1.3× 27 0.8× 122 3.8× 15 0.8× 50 337
A. A. DUNK United Kingdom 11 209 1.7× 167 1.4× 27 0.8× 74 2.3× 13 0.7× 18 338
Emily Truong United States 11 177 1.4× 314 2.6× 13 0.4× 83 2.6× 10 0.5× 15 382
Petra Munda Austria 9 187 1.5× 247 2.1× 30 0.9× 50 1.6× 5 0.3× 20 319

Countries citing papers authored by Ashraf Omar

Since Specialization
Citations

This map shows the geographic impact of Ashraf Omar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashraf Omar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashraf Omar more than expected).

Fields of papers citing papers by Ashraf Omar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashraf Omar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashraf Omar. The network helps show where Ashraf Omar may publish in the future.

Co-authorship network of co-authors of Ashraf Omar

This figure shows the co-authorship network connecting the top 25 collaborators of Ashraf Omar. A scholar is included among the top collaborators of Ashraf Omar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashraf Omar. Ashraf Omar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Asombang, Akwi W., Samuel O. Antwi, Abidemi Omonisi, et al.. (2025). Establishing cancer registries in Africa — focus on hepatopancreatobiliary cancers. Nature Reviews Gastroenterology & Hepatology. 23(2). 189–200.
2.
Gharib, Hany S., et al.. (2025). Role of Ascobien, Potassium Silicate Foliar Application in Alleviating Water Stress Effect on Wheat.. Egyptian Journal of Soil Science. 65(3). 0–0.
3.
Jenkins, Jan, et al.. (2024). Donor and recipient risk factors for the development of primary graft dysfunction following lung transplantation. Frontiers in Immunology. 15. 1341675–1341675. 7 indexed citations
4.
Jenkins, Jan, Juan Farina, Ashraf Omar, et al.. (2024). Lung Transplantation in the United States for COVID-19 Related Lung Disease During the Pandemic. Lung. 202(5). 723–737. 2 indexed citations
5.
Waked, Imam, Kakil Ibrahim Rasul, Wael Abdel‐Razek, et al.. (2023). Multidisciplinary consensus recommendations for management of hepatocellular carcinoma in Middle East and North Africa region. Liver International. 43(10). 2062–2077. 5 indexed citations
7.
Azim, Hamdy A., Ashraf Omar, Mohamed Shaker, et al.. (2018). Sorafenib plus tegafur–uracil (UFT) versus sorafenib as first line systemic treatment for patients with advanced stage HCC: a Phase II trial (ESLC01 study). Journal of Hepatocellular Carcinoma. Volume 5. 109–119. 19 indexed citations
8.
Attallah, Abdelfattah M., et al.. (2018). Extracellular Matrix Proteins Substantiate IL-28B T allele Effect on Histological Outcome of Chronic Hepatitis C. Annals of Hepatology. 17(4). 569–576. 6 indexed citations
9.
Elbaz, Tamer, Magdy El‐Serafy, Wafaa Elakel, et al.. (2017). Serious Adverse Events with Sofosbuvir Combined with Interferon and Ribavirin: Real-Life Egyptian Experience. Journal of Interferon & Cytokine Research. 37(8). 348–353. 4 indexed citations
10.
Omar, Ashraf, Ghassan K. Abou‐Alfa, Ahmed Khairy, & Heba Omar. (2013). Risk factors for developing hepatocellular carcinoma in Egypt.. PubMed. 2(4). 43–43. 50 indexed citations
11.
Ramadan, Mahmoud M., et al.. (2013). Interictal Electrocardiographic and Echocardiographic Changes in Patients With Generalized Tonic-Clonic Seizures. International Heart Journal. 54(3). 171–175. 18 indexed citations
12.
Omar, Ashraf, et al.. (2012). Cardiac functions in patients with sepsis and septic shock. The Egyptian Heart Journal. 64(4). 191–196. 7 indexed citations
13.
Mabrouk, Mahasen, Gamal Esmat, Ayman Yosry, et al.. (2012). Health-related quality of life in Egyptian patients after liver transplantation. Annals of Hepatology. 11(6). 882–890. 16 indexed citations
14.
Omar, Ashraf, et al.. (2011). Plasma Levels of Resistin and Ghrelin Before and After Treatment in Patients With Hyperthyroidism. Endocrine Practice. 18(3). 376–381. 17 indexed citations
15.
Bahnassy, Abeer A., Abdel‐Rahman N. Zekri, Samah A. Loutfy, et al.. (2011). The role of cyclins and cyclin dependent kinases in development and progression of hepatitis C virus-genotype 4-associated hepatitis and hepatocellular carcinoma. Experimental and Molecular Pathology. 91(2). 643–652. 8 indexed citations
16.
Yosry, Ayman, Gamal Esmat, Magdy El‐Serafy, et al.. (2009). Recurrence of hepatitis C virus (genotype 4) infection after living-donor liver transplant in Egyptian patients.. PubMed. 7(3). 157–63. 10 indexed citations
17.
El‐Serafy, Magdy, Ashraf Omar, Ayman Yosry, et al.. (2009). Quality of life of Egyptian donors after living-related liver transplantation. Arab Journal of Gastroenterology. 10(1). 21–24. 3 indexed citations
18.
Zekri, Abdel‐Rahman N., et al.. (2007). Genetic distance and heterogenecity between quasispecies is a critical predictor to IFN response in Egyptian patients with HCV genotype-4.. Virology Journal. 4(1). 16–16. 22 indexed citations
19.
Zekri, Abdel‐Rahman N., et al.. (2005). TRUGENE sequencing versus INNO-LiPA for sub-genotyping of HCV genotype-4. Journal of Medical Virology. 75(3). 412–420. 28 indexed citations
20.
El-Din, Hanaa M. Alam, et al.. (2004). TRUGENE sequencing versus INNO- LiPA for sub-genotyping of HCV genotype-4. 1(1). 59–59. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026